Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in Advanced Soft Tissue Sarcoma
NCT00053794Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jun 2003
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in soft tissue sarcoma (STS), sponsored by Canadian Cancer Trials Group. Started Jun 2003; status: completed.
02
Drugs
perifosine
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00053794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053794.